Small Molecule
Targeted Cancer Therapy Market - Global Industry Analysis, Size, Share,
Growth, Trends And Forecast, 2013 - 2019
Small
molecule targeted cancer therapies are drugs designed to block the growth of
cancerous cells. Conventional cytotoxic medications and chemotherapies usually
destroys rapidly dividing cancer cells by inhibiting cell division process.
However, small molecule targeted therapies destroys cancerous cells with fewer
side effects and high precision. Small molecule targeted cancer therapies can
be used for the treatment of various cancers such as prostate cancer, multiple
myeloma, breast cancer, lymphoma, melanoma and other cancers.
Visit Complete Report Here: http://www.marketresearchreports.biz/analysis-details/small-molecule-targeted-cancer-therapy-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Targeted
cancer drugs are broadly classified as follows:
- Small
Molecules
- Monoclonal
Antibodies
- Small
Molecule Drug conjugates
Small
molecules can further be classified as follows:
- Small
molecule proteasome inhibitor (e.g. Bortezomib)
- Small
molecule cyclin-dependent kinase inhibitor (e.g. Seliciclib)
- Small
molecule tyrosine kinase inhibitor (e.g. Imatinib)
Geographically,
North America is the leading market due to the rise incancer cases. According
to the International Agency for Research on Cancer (IARC), around 13 million
new cancer cases has been diagnosed worldwide. Moreover, according to the
World Cancer Report, incidence rate of cancer could further rise by 50% to 15
million new cancer cases by 2020. Furthermore, the European and Asian-Pacific
regions are expected to witness increased market traction due to
commercialization of target oriented economic drugs.
The
major factors driving this market are rise in incidence rate of cancer,
minimal adverse effects, targeted approach and high adoption rate.
Additionally, more number of blockbuster drugs such as Novartis’s Glivec are
losing their patents, leaving significant opportunities for manufacturers of
targeted cancer drugs. However, high developmental costs, stringent regulatory
policies andlow awareness are some of the restraints that could impede the
growth of the market.
Some
of the market players in this industry segment are Abbott Laboratories, Bayer
HealthCare AG, Boehringer Ingelheim GmbH, CytokineticsInc., GlaxoSmithKline
plc, Hospira Inc. , OncoGenex Pharmaceuticals Inc., and others.
This
research report analyzes this market depending on its market segments, major
geographies, and current market trends. Geographies analyzed under this
research report include
- North
America
- Asia
Pacific
- Europe
- Rest
of the World
This
report provides comprehensive analysis of
- Market
growth drivers
- Factors
limiting market growth
- Current
market trends
- Market
structure
- Market
projections for upcoming years
This
report is a complete study of current trends in the market, industry growth
drivers, and restraints. It provides market projections for the coming years.
It includes analysis of recent developments in technology, Porter’s five force
model analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
Reasons
for Buying this Report
- This
report provides pin-point analysis for changing competitive dynamics
- It
provides a forward looking perspective on different factors driving or
restraining market growth
- It
provides a technological growth map over time to understand the industry
growth rate
- It
provides a seven-year forecast assessed on the basis of how the market is
predicted to grow
- It
helps in understanding the key product segments and their future
- It
provides pin point analysis of changing competition dynamics and keeps
you ahead of competitors
- It
helps in making informed business decisions by having complete insights
of market and by making in-depth analysis of market segments
- It
provides distinctive graphics and exemplified SWOT analysis of major
market segments
Contact US:
Office: United States
|
State Tower
90 State Street, Suite 700 Albany, NY 12207 United States |
No comments:
Post a Comment